ONCASPAR (PEGASPARGASE)
NCASPAR (pegaspargase) is indicated as a component of a multi-agent chemotherapeutic regimen for the first–line treatment of patients with acute lymphoblastic leukemia (ALL) and for the treatment of patients with ALL and hypersensitivity to native forms of L-asparaginase.
ONCASPAR (PEGASPARGASE)
Industry:
Medical Device
Founded:
1986-01-01
Website Url:
http://www.oncaspar.com
Status:
Active
Contact:
844-229-7575
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Tag Manager Amazon Amazon Virginia Region DigiCert SSL Pound Sterling Typekit Japanese Yen
Official Site Inspections
http://www.oncaspar.com Semrush global rank: 6.58 M Semrush visits lastest month: 954
- Host name: 20.232.9.129
- IP address: 20.232.9.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 